Carvedilol

# Carvedilol ## Overview - **Classification**: Alpha- and Beta-Blocker (Non-selective beta, selective alpha-1) - **Mechanism**: Blocks $\beta_1$, $\beta_2$, and $\alpha_1$ receptors. Causes peripheral vasodilation and reduces heart rate/contractility. ## Primary Indications 1. **Heart Failure (HF)**: Mild-to-severe stable chronic heart failure. 2. **Hypertension (HTN)**: Treatment of essential hypertension. 3. **Left Ventricular Dysfunction (LVD)**: Post-Myocardial Infarction (MI). ## Adult Dosing ### Standard Dosing **Heart Failure (HF)** (Start low, titrate slow) - **Initial Dose**: **3.125 mg** - **Frequency**: Twice daily (BID) - **Titration**: Double dose every 2 weeks as tolerated. - **Target Dose**: Based on weight: **25 mg BID** (<85 kg) or **50 mg BID** (>85 kg) **Hypertension (HTN)** - **Initial Dose**: **6.25 mg** - **Frequency**: Twice daily (BID) - **Maintenance Dose**: **12.5 mg to 25 mg** BID - **Maximum Dose**: **50 mg** daily **Post-MI LVD** - **Initial Dose**: **6.25 mg** - **Frequency**: Twice daily (BID) - **Target Dose**: Gradually increase over 3–10 days to **25 mg** BID. ### Dose Adjustments - **Renal Impairment**: No specific initial dose adjustment needed. - **Hepatic Impairment**: **Contraindicated** in severe liver impairment. Use with caution in mild-to-moderate dysfunction. - **Elderly Patients**: No specific adjustment; higher risk of orthostatic hypotension. ## Pediatric Dosing Carvedilol use in pediatrics is off-label, mainly for HF and HTN. ### Neonates (0-28 days) - **Dose**: Data limited; use generally discouraged or reserved for specialists only. - **Special Notes**: High risk of bradycardia and hypotension; monitor closely. ### Infants (1-12 months) - **Dose (HF)**: Start at **0.01 mg/kg/dose** - **Frequency**: Twice daily (BID) - **Titration**: Double dose every 2 weeks to maximum of 0.5 mg/kg/day. ### Children (1-12 years) - **Dose (HF)**: Start at **0.01 to 0.05 mg/kg/dose** - **Frequency**: Twice daily (BID) - **Maximum**: Do not exceed **25 mg** daily total. ### Adolescents (13-18 years) - **Dose**: Approach adult dosing, starting low. - **Frequency**: Twice daily (BID) - **Maximum**: **50 mg** daily. ## Safety Information ### Contraindications - **Absolute**: **Decompensated heart failure** requiring IV inotropes. - **Absolute**: Bronchial asthma or severe **COPD**. - **Absolute**: Second or third-degree **AV block** (without pacemaker). - **Absolute**: Severe sinus bradycardia (<50 bpm). - **Absolute**: Severe hepatic impairment. ### Common Adverse Effects - **Very Common (>10%)**: Dizziness, generalized fatigue/asthenia. - **Common (1-10%)**: Hypotension, bradycardia, visual disturbance. - **Common (1-10%)**: Hyperglycemia (especially in diabetics), diarrhea. - **Serious but Rare**: Stevens-Johnson syndrome, severe liver injury. ### Key Drug Interactions - **CYP2D6 Inhibitors (e.g., Fluoxetine)**: May increase carvedilol plasma concentrations. Monitor for bradycardia. - **Rifampin**: Significant CYP induction, reducing carvedilol levels. Monitor effect; higher dose may be needed. - **Digitalis Glycosides**: Increased risk of bradycardia and AV block. Monitor heart rate/rhythm closely. - **Insulin/Oral Hypoglycemics**: Carvedilol may mask symptoms of hypoglycemia (e.g., tremors). ## Monitoring & Follow-up - **Before Treatment**: Baseline blood pressure (BP), heart rate (HR), liver function tests (LFTs). - **During Treatment**: BP, HR (especially during titration). - **During Treatment**: Fluid status and signs of worsening HF. - **Clinical Signs**: Monitor for dizziness, worsening shortness of breath, or weight gain. ## Clinical Pearls - 💡 **Titration Crucial**: Mandatory slow titration, especially in HF, to minimize hypotension risk. - 💡 **Take with Food**: Recommend taking Carvedilol **with food** to slow absorption and reduce orthostatic hypotension. - 💡 **Never Stop Abruptly**: Abrupt withdrawal can exacerbate angina, MI, or hypertension. Taper dose over 1–2 weeks. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.